Companies: 10,795·Total market cap: $144.5T
Labcorp Holdings Inc.

Labcorp Holdings Inc.

LHNYSEHealthcare● Active
$262.01
$-3.14(-1.18%)
Market Cap$21.5B
P/E Ratio
52W High$293.72
52W Low$241.81
Overview

Labcorp Holdings Inc. (LH) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · LH · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$0.88B$0.75B$0.38B$1.00B$2.38B
Depreciation & Amort.$0.68B$0.64B$0.58B$0.54B$0.58B
Stock-Based Comp.$0.13B$0.12B$0.13B$0.12B$0.13B
Change in Working Capital($0.53B)($0.15B)($0.36B)($0.60B)($0.26B)
Net Cash from Operations$1.64B$1.59B$1.33B$1.96B$3.11B
Investing Activities
Capital Expenditure($0.43B)($0.49B)($0.45B)($0.48B)($0.46B)
Purchases of Investments($0.19B)($0.06B)($0.03B)($0.02B)($0.03B)
Sales of Investments$0.01B$0.00B$0.01B$0.01B$0.01B
Net Cash from Investing($1.19B)($1.37B)($1.17B)($1.65B)($0.88B)
Financing Activities
Common Stock Repurchased($0.45B)($0.25B)($1.04B)($1.15B)($1.72B)
Dividends Paid($0.24B)($0.24B)($0.25B)($0.20B)$0.00B
Debt Issued / Repaid($0.78B)$1.00B($0.30B)$0.00B($0.38B)
Net Cash from Financing($1.46B)$0.78B($0.06B)($1.32B)($2.07B)
Free Cash Flow
Free Cash Flow$1.21B$1.10B$0.87B$1.47B$2.65B
FCF Margin %(computed)8.64%8.42%7.19%12.42%20.17%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more Labcorp Holdings Inc. data

About Labcorp Holdings Inc. (LH) Cash Flow Statement

Labcorp Holdings Inc. generated operating cash flow of $1.64B and free cash flow of $1.21B for 2025 — a FCF margin of 8.64%. Capital expenditure was ($0.43B).

Frequently asked questions

LH · 4 questions

Labcorp Holdings Inc. generated free cash flow of $1.21B for 2025, up 10.0% year-over-year.

LH free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10